Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Chondrosarcoma epidemiology and demographics

Introduction

Overview

Overview

Chondrosarcoma is the second most common malignant primary tumor of bone. It is most frequently diagnosed in patients in their 4th and 5th decades of life. Men are slightly more affected by chondrosarcoma than women. There is no racial predilection to chondrosarcoma.

Epidemiology and Demographics

Epidemiology and Demographics

Incidence

  • Chondrosarcoma is the second most common primary bone sarcoma.[1]
  • The incidence of chondrosarcoam is approximately 1 per 100,000 individuals worldwide.[2]

Age

  • Chondrosarcoma is most frequently diagnosed in patients in their 4th and 5th decades of life.[3]
  • The average age at presentation is 51 years.

Race

  • There is no racial predilection to chondrosarcoma.[2]

Gender

  • Chondrosarcoma affects men and women almost equally with slight male predominance.[4]
  • Exception to this is the clear cell sub-type which has significant male preponderance.
  • The male to female ratio is almost 1:1 except for clear cell chondrosarcoma it is 2.4:1.
References

References

  1. ↑ Peabody, Terrance (2014). Orthopaedic oncologyΒ : primary and metastatic tumors of the skeletal system. Cham: Springer. ISBNΒ 9783319073224.
  2. ↑ 2.0 2.1 Lex JR, Evans S, Stevenson JD, Parry M, Jeys LM, Grimer RJ (2018). “Dedifferentiated chondrosarcoma of the pelvis: clinical outcomes and current treatment”. Clin Sarcoma Res. 8: 23. doi:10.1186/s13569-018-0110-1. PMCΒ 6293503. PMIDΒ 30559960.
  3. ↑ Unni KK (2001). “Cartilaginous lesions of bone”. J Orthop Sci. 6 (5): 457–72. PMIDΒ 11845358.
  4. ↑ Weber KL, Raymond AK (2002). “Low-grade/dedifferentiated/high-grade chondrosarcoma: a case of histological and biological progression”. Iowa Orthop J. 22: 75–80. PMCΒ 1888368. PMIDΒ 12180616.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Rohan A. Bhimani, M.B.B.S., D.N.B., M.Ch.[2]